<DOC>
	<DOCNO>NCT01051336</DOCNO>
	<brief_summary>The aim protocol evaluate tolerability Taris placebo system development program provide key safety tolerability data Taris platform .</brief_summary>
	<brief_title>Safety Tolerability Study Taris Placebo System</brief_title>
	<detailed_description />
	<criteria>Healthy female volunteer , 18 55 year age Body weight &gt; 100 lbs BMI ( body mass index ) within range 1830 kg/m2 A score less 11 pelvic pain/urgencyfrequency scale ( PUF ) Presence bladder urethra anatomical feature , opinion investigator , might prevent safe placement , indwell use , removal TARIS placebo system History significant urogenital surgery ( type bladder suspension , prolapse repair , incontinence procedure , vaginal hysterectomy ) History kidney stone formation Chronic recur bacterial viral infection urogenital system</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2010</verification_date>
	<keyword>TARIS Placebo</keyword>
	<keyword>Bladder</keyword>
	<keyword>Interstitial Cystitis</keyword>
	<keyword>Normal Healthy Volunteers</keyword>
</DOC>